Presentation is loading. Please wait.

Presentation is loading. Please wait.

A: Executive function performance assessed by D-KEFS Trail Making task (Number-Letter Switching) and depicted according to presence or absence of CVD in.

Published by정원 호 Modified over 5 years ago

Similar presentations

Presentation on theme: "A: Executive function performance assessed by D-KEFS Trail Making task (Number-Letter Switching) and depicted according to presence or absence of CVD in."— Presentation transcript:

1 A: Executive function performance assessed by D-KEFS Trail Making task (Number-Letter Switching) and depicted according to presence or absence of CVD in Medalists. A: Executive function performance assessed by D-KEFS Trail Making task (Number-Letter Switching) and depicted according to presence or absence of CVD in Medalists. Means ± SD are presented. *Adjusted for lipids, statin use, and BMI. B: Psychomotor speed measured by Grooved Pegboard assessment and depicted according to presence or absence of PDR in Medalists. Means ± SD are presented. *Adjusted for age. Gail Musen et al. Dia Care 2018;41: ©2018 by American Diabetes Association

Download ppt "A: Executive function performance assessed by D-KEFS Trail Making task (Number-Letter Switching) and depicted according to presence or absence of CVD in."

Similar presentations

Characteristics of 3921 Men Seen by a Primary Care Provider Steven A. Grover, et al, Arch Intern Med. 2005;166:213-219.

Characteristics of 3921 Men Seen by a Primary Care Provider Steven A. Grover, et al, Arch Intern Med. 2005;166:
The means and SDs of the data from all Glucommander runs from 1984 to 1998 are graphed. The means and SDs of the data from all Glucommander runs from 1984.

The means and SDs of the data from all Glucommander runs from 1984 to 1998 are graphed. The means and SDs of the data from all Glucommander runs from 1984.
NAFLD (nonalcoholic fatty liver disease), CVD, and type 2 diabetes: Details of the study design Targher G et al. Diabetes Care 2007;30:1212-8.

NAFLD (nonalcoholic fatty liver disease), CVD, and type 2 diabetes: Details of the study design Targher G et al. Diabetes Care 2007;30:
Baseline Characteristics

Baseline Characteristics
Kaplan–Meier estimates of the incidence of first heart failure hospitalization during follow-up according to the statin category among patients with type.

Kaplan–Meier estimates of the incidence of first heart failure hospitalization during follow-up according to the statin category among patients with type.
Changes in weight and body mass index (BMI) associated with quality improvement. Changes in weight and body mass index (BMI) associated with quality improvement.

Changes in weight and body mass index (BMI) associated with quality improvement. Changes in weight and body mass index (BMI) associated with quality improvement.
Intensity of statin treatment and possible lipid lowering treatment intolerance and/or ineffectiveness issues among patients with type 2 diabetes (aged.

Intensity of statin treatment and possible lipid lowering treatment intolerance and/or ineffectiveness issues among patients with type 2 diabetes (aged.
Persistent organic pollutants and diabetes - Spearman correlation coefficients* among six POPs with age, sex, race and ethnicity, poverty income.

Persistent organic pollutants and diabetes - Spearman correlation coefficients* among six POPs with age, sex, race and ethnicity, poverty income.
Serum 25(OH)D levels stratified by the presence or absence of nephropathy. Serum 25(OH)D levels stratified by the presence or absence of nephropathy. The.

Serum 25(OH)D levels stratified by the presence or absence of nephropathy. Serum 25(OH)D levels stratified by the presence or absence of nephropathy. The.
Incidence rates and HRs for total cardiovascular events and stroke stratified by the TCF7L2-rs7903146 polymorphism and the dietary intervention group after.

Incidence rates and HRs for total cardiovascular events and stroke stratified by the TCF7L2-rs polymorphism and the dietary intervention group after.
The rates of occurrences of cardiovascular, cerebrovascular, and all events expressed in cases per 1, 000 patient-years in diabetic subgroups divided by.

The rates of occurrences of cardiovascular, cerebrovascular, and all events expressed in cases per 1, 000 patient-years in diabetic subgroups divided by.
Incidence of diabetes over time depends on GIS

Incidence of diabetes over time depends on GIS
Trends in prevalence of diabetes in middle-aged women grouped according to BMI at the first survey of the ALSWH. ▪, healthy (n = 5,252); ♦, overweight.

Trends in prevalence of diabetes in middle-aged women grouped according to BMI at the first survey of the ALSWH. ▪, healthy (n = 5,252); ♦, overweight.
Schematic representation of an MR analysis.

Schematic representation of an MR analysis.
Incidences (%) for the development (for individuals without MetS at baseline, n = 125) (□) and the resolution (for individuals with MetS at baseline, n.

Incidences (%) for the development (for individuals without MetS at baseline, n = 125) (□) and the resolution (for individuals with MetS at baseline, n.
Predicted percentage of home discharge by diabetes group adjusting for all variables listed in the age-centered logistic regression model with examination.

Predicted percentage of home discharge by diabetes group adjusting for all variables listed in the age-centered logistic regression model with examination.
Age-adjusted OR (A) and multivariate-adjusted OR (B) and 95% CI for the presence of retinopathy and albuminuria by quintiles of WBC count in 3,776 patients.

Age-adjusted OR (A) and multivariate-adjusted OR (B) and 95% CI for the presence of retinopathy and albuminuria by quintiles of WBC count in 3,776 patients.
An algorithm depicting the basic approach to the Charcot foot

An algorithm depicting the basic approach to the Charcot foot
Prevalence of high SAT or high VAT by BMI category in women (A) and men (B) and by waist circumference category in women (C) and men (D). Prevalence of.

Prevalence of high SAT or high VAT by BMI category in women (A) and men (B) and by waist circumference category in women (C) and men (D). Prevalence of.
FMD and PWV of patients with diabetes with (T2DM-SCT) or without (T2DM) SCT and of healthy individuals with (SCT) or without (CONT) SCT. FMD measured at.

FMD and PWV of patients with diabetes with (T2DM-SCT) or without (T2DM) SCT and of healthy individuals with (SCT) or without (CONT) SCT. FMD measured at.

Similar presentations

Ads by Google